• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Quantifying cell death in the myocardium: myosin specific antibody in the evaluation of membrane defects.

作者信息

Haber E

出版信息

J Mol Cell Cardiol. 1985 Jul;17 Suppl 2:53-8. doi: 10.1016/0022-2828(85)90008-2.

DOI:10.1016/0022-2828(85)90008-2
PMID:2993633
Abstract

Methods for evaluating cardiac myocyte necrosis utilizing antibodies specific for the heavy or light chains of cardiac myosin are reviewed. Cell death, associated with sarcolemmal disruption, results in the leakage of myosin light chains from the cytoplasm as well as the accessibility of myosin heavy chains to exogenous specific antibodies. Measurement of plasma light chain concentration has been useful in the diagnosis of myocardial infarction, though more recently, patients with congestive cardiomyopathy associated with an inflammatory infiltrate have been identified by an elevated plasma light chain concentration. The binding of myosin heavy chains to necrotic myocytes has been useful in the study of mechanisms of ischemic cell death in cell culture, in the diagnosis and quantification of myocardial infarction, both experimentally and clinically, and more recently in the study of experimental myocarditis and cardiac transplantation. It is hoped that these methods may evolve as useful clinical tools in the identification of those cardiomyopathy patients whose course is characterized by rapid myocyte loss.

摘要

相似文献

1
Quantifying cell death in the myocardium: myosin specific antibody in the evaluation of membrane defects.
J Mol Cell Cardiol. 1985 Jul;17 Suppl 2:53-8. doi: 10.1016/0022-2828(85)90008-2.
2
Is In-111 antimyosin antibody a useful diagnostic marker for evaluation of early cardiac allograft rejection?铟 - 111抗肌球蛋白抗体是否是评估早期心脏移植排斥反应的有用诊断标志物?
Transplant Proc. 1988 Feb;20(1 Suppl 1):778-81.
3
[Evaluation of myocardial damage with radioactive isotopes].[放射性同位素评估心肌损伤]
Rev Esp Cardiol. 1994;47 Suppl 4:132-9.
4
Monoclonal Fab antimyosin in cardiac imaging.用于心脏成像的单克隆Fab抗肌球蛋白
Clin Cardiol. 1992 Mar;15(3):145-53. doi: 10.1002/clc.4960150304.
5
Imaging necrotic myocardium: detection with 99mTc-pyrophosphate and radiolabeled antimyosin.梗死心肌成像:用99m锝-焦磷酸盐和放射性标记抗肌凝蛋白进行检测。
Cardiol Clin. 1989 Aug;7(3):577-88.
6
[Methods of determining the extent of a myocardial infarct].[确定心肌梗死范围的方法]
Sov Med. 1983(1):52-5.
7
Nuclear cardiology (first of two parts).核医学心脏病学(两部分中的第一部分)
N Engl J Med. 1981 Oct 1;305(14):799-807. doi: 10.1056/NEJM198110013051405.
8
Acute myocardial infarct scintigraphy with infarct-avid radiotracers.使用梗死灶亲和性放射性示踪剂的急性心肌梗死闪烁扫描术。
Med Clin North Am. 1980 Jan;64(1):119-44. doi: 10.1016/s0025-7125(16)31628-5.
9
Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate.
J Nucl Med. 1987 Jan;28(1):76-82.
10
Radionuclide imaging in myocardial sarcoidosis. Demonstration of myocardial uptake of technetium pyrophosphate99m and gallium.心肌结节病的放射性核素显像。99m焦磷酸锝和镓心肌摄取的显示。
Chest. 1983 Mar;83(3):578-80. doi: 10.1378/chest.83.3.578.

引用本文的文献

1
Diagnosis of cardiac allograft rejection by the detection of circulating plasma cardiac myosin light chains.
Jpn J Surg. 1990 Mar;20(2):212-6. doi: 10.1007/BF02470771.